9-fluorenylmethoxycarbonyl (fmoc)-based solidphase strategy (Solid Phase Inc)
90
Structured Review
Solid Phase Inc
9-fluorenylmethoxycarbonyl (fmoc)-based solidphase strategy
9 Fluorenylmethoxycarbonyl (Fmoc) Based Solidphase Strategy, supplied by Solid Phase Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fmoc-solidphase+strategy/9+fluorenylmethoxycarbonyl++fmoc++based+solidphase+strategy/pm33091529-130-19-21
Average 90 stars, based on 1 article reviews
9 Fluorenylmethoxycarbonyl (Fmoc) Based Solidphase Strategy, supplied by Solid Phase Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fmoc-solidphase+strategy/9+fluorenylmethoxycarbonyl++fmoc++based+solidphase+strategy/pm33091529-130-19-21
Average 90 stars, based on 1 article reviews
9-fluorenylmethoxycarbonyl (fmoc)-based solidphase strategy - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Design, synthesis and biochemical investigation, by in vitro luciferase reporter system, of peptide nucleic acids as new inhibitors of miR-509-3p involved in the regulation of cystic fibrosis disease-gene expression Article Snippet: Recently, microRNAs (miRNAs) were identified as being able to inhibit the expression of the Cystic Fibrosis Transmembrane Regulator (CFTR) disease-gene of Cystic Fibrosis (CF) and CFTR-Related Disorders (CFTRRD).. This study shows the use of peptide nucleic acids (PNAs) as inhibitors of miR-509-3p, one of the CFTR regulating miRNAs, by reverting the expression of the luciferase gene containing the 30UTR of CFTR gene. |